AAAAAA

   
Results: 1-18 |
Results: 18
Management of hepatitis B: 2000 - Summary of a workshop
Authors: Lok, AS Heathcote, EJ Hoofnagle, JH
Citation: As. Lok et al., Management of hepatitis B: 2000 - Summary of a workshop, GASTROENTY, 120(7), 2001, pp. 1828-1853
Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment
Authors: Comanor, L Anderson, F Ghany, M Perrillo, R Heathcote, EJ Sherlock, C Zitron, I Hendricks, D Gordon, SC
Citation: L. Comanor et al., Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment, AM J GASTRO, 96(10), 2001, pp. 2968-2972
Serum cytokine values and fatigue in chronic hepatitis C infection
Authors: Gershon, AS Margulies, M Gorczynski, RM Heathcote, EJ
Citation: As. Gershon et al., Serum cytokine values and fatigue in chronic hepatitis C infection, J VIRAL HEP, 7(6), 2000, pp. 397-402
Management of primary biliary cirrhosis
Authors: Heathcote, EJ
Citation: Ej. Heathcote, Management of primary biliary cirrhosis, HEPATOLOGY, 31(4), 2000, pp. 1005-1013
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
Authors: Villeneuve, JP Condreay, LD Willems, B Pomier-Layrargues, G Fenyves, D Bilodeau, M Leduc, R Peltekian, K Wong, F Margulies, M Heathcote, EJ
Citation: Jp. Villeneuve et al., Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B, HEPATOLOGY, 31(1), 2000, pp. 207-210
Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?
Authors: Comay, D Cauch-Dudek, K Hemphill, D Diamandis, E Wanless, I Heathcote, EJ
Citation: D. Comay et al., Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?, DIG DIS SCI, 45(10), 2000, pp. 2018-2021
Ursodeoxycholic acid for primary biliary cirrhosis
Authors: Lindor, KD Poupon, R Poupon, R Heathcote, EJ Therneau, T
Citation: Kd. Lindor et al., Ursodeoxycholic acid for primary biliary cirrhosis, LANCET, 355(9204), 2000, pp. 657-658
Peginterferon alfa-2a in patients with chronic hepatitis C
Authors: Zeuzem, S Feinman, SV Rasenack, J Heathcote, EJ Lai, MY Gane, E O'Grady, J Reichen, J Diago, M Lin, A Hoffman, J Brunda, MJ
Citation: S. Zeuzem et al., Peginterferon alfa-2a in patients with chronic hepatitis C, N ENG J MED, 343(23), 2000, pp. 1666-1672
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis
Authors: Heathcote, EJ Shiffman, ML Cooksley, WGE Dusheiko, GM Lee, SS Balart, L Reindollar, R Reddy, RK Wright, TL Lin, A Hoffman, J De Pamphilis, J
Citation: Ej. Heathcote et al., Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis, N ENG J MED, 343(23), 2000, pp. 1673-1680
Vitamin D-receptor genotypes as independent genetic predictors of decreased bane mineral density in primary biliary cirrhosis
Authors: Springer, JE Cole, DEC Rubin, LA Cauch-Dudek, K Harewood, L Evrovski, J Peltekova, VD Heathcote, EJ
Citation: Je. Springer et al., Vitamin D-receptor genotypes as independent genetic predictors of decreased bane mineral density in primary biliary cirrhosis, GASTROENTY, 118(1), 2000, pp. 145-151
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis
Authors: Heathcote, EJ Stone, J Cauch-Dudek, K Poupon, R Chazouilleres, O Lindor, KD Petz, J Dickson, ER Poupon, RE
Citation: Ej. Heathcote et al., Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis, LIVER TR S, 5(4), 1999, pp. 269-274
Evidence-based therapy of primary biliary cirrhosis
Authors: Heathcote, EJ
Citation: Ej. Heathcote, Evidence-based therapy of primary biliary cirrhosis, EUR J GASTR, 11(6), 1999, pp. 607-615
Antiphospholipid antibody syndrome associated with hepatitis C infection
Authors: Puri, V Bookman, A Yeo, E Cameron, R Heathcote, EJ
Citation: V. Puri et al., Antiphospholipid antibody syndrome associated with hepatitis C infection, J RHEUMATOL, 26(2), 1999, pp. 509-510
Racial differences in responses to therapy with interferon in chronic hepatitis C
Authors: Reddy, KR Hoofnagle, JH Tong, MJ Lee, WM Pockros, P Heathcote, EJ Albert, D Joh, T
Citation: Kr. Reddy et al., Racial differences in responses to therapy with interferon in chronic hepatitis C, HEPATOLOGY, 30(3), 1999, pp. 787-793
Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia
Authors: Rasul, I Shepherd, FA Kamel-Reid, S Krajden, M Pantalony, D Heathcote, EJ
Citation: I. Rasul et al., Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia, HEPATOLOGY, 29(2), 1999, pp. 543-547
Clinical significance of serum bilirubin levels under ursodeoxycholic acidtherapy in patients with primary biliary cirrhosis
Authors: Bonnand, AM Heathcote, EJ Lindor, KD Poupon, RE
Citation: Am. Bonnand et al., Clinical significance of serum bilirubin levels under ursodeoxycholic acidtherapy in patients with primary biliary cirrhosis, HEPATOLOGY, 29(1), 1999, pp. 39-43
Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population
Authors: Chen, DK Yim, C O'Rourke, K Krajden, M Wong, DKH Heathcote, EJ
Citation: Dk. Chen et al., Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population, J HEPATOL, 30(4), 1999, pp. 557-563
Asymptomatic primary biliary cirrhosis: A study of its natural history andprognosis
Authors: Springer, J Cauch-Dudek, K O'Rourke, K Wanless, IR Heathcote, EJ
Citation: J. Springer et al., Asymptomatic primary biliary cirrhosis: A study of its natural history andprognosis, AM J GASTRO, 94(1), 1999, pp. 47-53
Risultati: 1-18 |